Restoration of ovarian function after orthotopic (intraovarian and periovarian) transplantation of cryopreserved ovarian tissue in a woman treated by bone marrow transplantation for sickle cell anaemia: Case report

被引:113
作者
Donnez, J
Dolmans, MM
Demylle, D
Jadoul, P
Pirard, C
Squifflet, J
Martinez-Madrid, B
Van Langendonckt, A
机构
[1] Catholic Univ Louvain, Serv Gynecol, Gynecol Res Unit, B-1200 Brussels, Belgium
[2] Catholic Univ Louvain, Dept Gynecol, Clin Univ St Luc, B-1200 Brussels, Belgium
关键词
chemotherapy; cryopreservation; ovarian cortex; orthotopic transplantation; reimplantation;
D O I
10.1093/humrep/dei268
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Ovarian function after orthotopic transplantation of cryopreserved ovarian tissue has been restored in women with malignant disease. Here the techniques are adapted for a non-cancer patient. In 1999, right oophorectomy was performed in a 21 year old woman before chemotherapy, prior to bone marrow transplantation. Ovarian cortex was frozen, according to a strict protocol. After thawing, ovarian cortex was reimplanted into the ovary and in a peritoneal window close to the ovary in 2004. Four-and-a-half months after reimplantation, LH, FSH, 17 beta-estradiol and progesterone levels, as well as ultrasonography, demonstrated the presence of an ovulatory cycle. After this cycle, the patient experienced two other ovulatory cycles, evidenced by FSH and 17 beta-estradiol concentrations, as well as ultrasound demonstration of a follicle. Follicular development was clearly observed in both the intraovarian site (1st and 2nd cycle) and the peritoneal window (3rd cycle). Restoration of endocrine ovarian function occurred after ovarian cortical strips, biopsied and cryopreserved before chemotherapy, were reimplanted into the ovary itself and a periovarian peritoneal window.
引用
收藏
页码:183 / 188
页数:6
相关论文
共 29 条
[21]   Ovarian function after transplantation of frozen, banked autologous ovarian tissue. [J].
Oktay, K ;
Karlikaya, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (25) :1919-1919
[22]   Embryo development after heterotopic transplantation of cryopreserved ovarian tissue [J].
Oktay, K ;
Buyuk, E ;
Veeck, L ;
Zaninovic, N ;
Xu, KP ;
Takeuchi, T ;
Opsahl, M ;
Rosenwaks, Z .
LANCET, 2004, 363 (9412) :837-840
[23]   Endocrine function and oocyte retrieval after autologous transplantation of ovarian cortical strips to the forearm [J].
Oktay, K ;
Economos, K ;
Kan, M ;
Rucinski, J ;
Veeck, L ;
Rosenwaks, Z .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (12) :1490-1493
[24]   Expression of transforming growth factor-alpha, epidermal growth factor, and epidermal growth factor receptor in follicles of human ovarian tissue before and after cryopreservation [J].
Qu, JP ;
Nisolle, M ;
Donnez, J .
FERTILITY AND STERILITY, 2000, 74 (01) :113-121
[25]   Orthotopic reimplantation of cryopreserved ovarian cortical strips after high-dose chemotherapy for Hodgkin's lymphoma [J].
Radford, JA ;
Lieberman, BA ;
Brison, DR ;
Smith, ARB ;
Critchlow, JD ;
Russell, SA ;
Watson, AJ ;
Clayton, JA ;
Harris, M ;
Gosden, RG ;
Shalet, SM .
LANCET, 2001, 357 (9263) :1172-1175
[26]   Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation [J].
Sanders, JE ;
Hawley, J ;
Levy, W ;
Gooley, T ;
Buckner, CD ;
Deeg, HJ ;
Doney, K ;
Storb, R ;
Sullivan, K ;
Witherspoon, R ;
Appelbaum, FR .
BLOOD, 1996, 87 (07) :3045-3052
[27]   Density and distribution of primordial follicles in single pieces of cortex from 21 patients and in individual pieces of cortex from three entire human ovaries [J].
Schmidt, KLT ;
Byskov, AG ;
Andersen, AN ;
Müller, J ;
Andersen, CY .
HUMAN REPRODUCTION, 2003, 18 (06) :1158-1164
[28]   Ovarian function after autologous bone marrow transplantation in childhood: high-dose busulfan is a major cause of ovarian failure [J].
Teinturier, C ;
Hartmann, O ;
Valteau-Couanet, D ;
Benhamou, E ;
Bougneres, PF .
BONE MARROW TRANSPLANTATION, 1998, 22 (10) :989-994
[29]   Fertility preservation for young patients with cancer: who is at risk and what can be offered? [J].
Wallace, WHB ;
Anderson, RA ;
Irvine, DS .
LANCET ONCOLOGY, 2005, 6 (04) :209-218